Skip to main content
Bernard Harris, MD, Preventive Medicine, Darby, PA

BernardAmielHarrisMDMPH

Preventive Medicine Darby, PA

Public Health & General Preventive Medicine, Addiction Medicine

Medical Director, consultant in addiction medicine and public health

Dr. Harris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Harris' full profile

Already have an account?

Summary

  • My career has been dedicated to public service. For 25 plus years I work with the Philadelphia Department of Public Health as director of an HIV AIDS clinic as well as a clinician II in the ambulatory Health division. I am currently practicing as a private consultant in public health and addiction medicine specialist. Professional interests also include radio and television production with a focus on public health issues.

Education & Training

  • Zuckerberg San Francisco General Hospital and Trauma Center
    Zuckerberg San Francisco General Hospital and Trauma CenterInternship, Transitional Year, 1980 - 1981
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 1980

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2022 - 2025
  • DE State Medical License
    DE State Medical License 2013 - 2025
  • NJ State Medical License
    NJ State Medical License 2013 - 2025
  • PA State Medical License
    PA State Medical License 1981 - 2024
  • American Board of Preventive Medicine Public Health & General Preventive Medicine
  • American Board of Preventive Medicine Addiction Medicine
  • American Society of Addiction MedicineFellow

Awards, Honors, & Recognition

  • Pinnacle Award for Achievement in Business and Professional Excellence Gillette corp and Harbon Publishing, 1991

Clinical Trials

Research History

  • Site Principle InvestigatorThe Ziagen Optimal Regimen and Resistance Observational (ZORRO) Trial. A Phase IV, open-label, community-based study conducted over 16 weeks at U.S. clinical practice sites to assess real-world safety/ tolerability and efficacy of abacavir- containing combination regimens.2000 - 2001

Professional Memberships